Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Clene Inc.
Biotech
FDA unconvinced by Clene’s request for accelerated approval tag
Clene continues to struggle to get anyone else to understand what it sees in CNM-Au8.
James Waldron
Dec 21, 2023 8:27am
Clene polishes tarnished ALS asset with long-term survival data
Aug 29, 2023 10:10am
Clene claims ALS therapy hits biomarker behind Qalsody approval
Jun 16, 2023 8:05am
Not so Clene break. Biotech's shares slump 34% on ALS flop
Oct 3, 2022 11:00am